谷内江昭宏.
慢性活動性EBV感染症と類縁疾患.
小児科 2018; 59: 1061-1069.

Shibata H, Yasumi T, Shimodera S, Hiejima E, Izawa K, Kawai T, Shirakawa R, Wada T, Nishikomori R, Horiuchi H, Ohara O, Ishii E, Heike T.
Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.
Blood. 2018; 131: 2016-2025. doi: 10.1182/blood-2017-10-812503.

種市尋宙, 太田邦雄.
【小児の治療指針】救急場面における初期対応 溺水.
小児科診療 2018; 81: 86-88.

Asano T, Okada S, Tsumura M, Yeh TW, Mitsui-Sekinaka K, Tsujita Y, Ichinose Y, Shimada A, Hashimoto K, Wada T, Imai K, Ohara O, Morio T, Nonoyama S, Kobayashi M.
Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
Front Immunol. 2018; 9: 568. doi: 10.3389/fimmu.2018.00568.

Wada T, Toma T, Miyazawa H, Koizumi E, Shirahashi T, Matsuda Y, Yachie A.
Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10.
Cytokine. 2018; 104: 143-146. doi: 10.1016/j.cyto.2017.10.007.

Wada T, Toma T, Miyazawa H, Koizumi E, Shirahashi T, Matsuda Y, Yachie A.
Characterization of skin blister fluids from children with Epstein-Barr virus- associated lymphoproliferative disease.
J Dermatol. 2018; 45: 444-449. doi: 10.1111/1346-8138.14226.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.
MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinaseγpathway.
Rheumatology (Oxford). 2018; 57: 718-726. doi: 10.1093/rheumatology/kex451.

谷内江昭宏.
【ヘルペスウイルス感染症の最近の知見】EBウイルス 急性EBウイルス感染症.
臨牀と研究 2018; 95: 366-371.

太田邦雄.
小児診療初期対応コース(JPLS)について.
東京小児科医会報別冊 2018; 36: 46-49.

Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A.
Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Clin Exp Immunol. 2018; 191: 349-355. doi: 10.1111/cei.13026.

Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, KonÉ-Paut I, Kostik M, Lovell D, Maritsi D, Nigrovic PA, Pal P, Ravelli A, Shimizu M, Stanevicha V, Vastert S, Woerner A, de Benedetti F, Grom AA.
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2018; 70: 409-419. doi: 10.1002/acr.23277.

Fujiki T, Nishimura R, Ikawa Y, Noguchi K, Mase S, Kuroda R, Araki R, Maeba H, Yachie A.
Hearing impairment accompanied with low-tone tinnitus during all trans retinoic acid containing chemotherapy.
Pediatr Blood Cancer. 2018; 65. doi: 10.1002/pbc.26864.

Tasaki Y, Shimizu M, Takarkura M, Ohta K, Yachie A.
Urinary aquaporin-2 as a possible objective biomarker of nocturnal polyuria.
Pediatr Int. 2018; 60: 192-194. doi: 10.1111/ped.13443.

Kinjo N, Hamada K, Hirayama C, Shimizu M.
Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome.
J Clin Apher. 2018; 33: 117-120. doi: 10.1002/jca.21570.

藤田直久, 伊川泰広, 根本育実, 谷内裕輔, 井上なつみ, 加藤明子, 谷内江昭宏.
特徴的なMRI 像と血清 IL-18高値を呈した急性発症型自己免疫性肝炎.
小児科臨床 2018; 71: 233-240.

谷内江昭宏.
泉熱再考 病原体と免疫応答.
小児感染免疫 2018; 29: 369-381.

小泉瑛子, 伊川泰広, 谷内江昭宏.
膿胸腔の多房化により胸腔鏡下手術を要した難治性肺炎随伴性胸水の1例.
小児感染免疫 2018; 29: 351-356.

Yoshida S, Nakanishi C, Okada H, Mori M, Yokawa J, Yoshimuta T, Ohta K, Konno T, Fujino N, Kawashiri MA, Yachie A, Yamagishi M, Hayashi K.
Characteristics of induced pluripotent stem cells from clinically divergent female monozygotic twins with Danon disease.
J Mol Cell Cardiol. 2018; 114: 234-242. doi: 10.1016/j.yjmcc.2017.11.019.

Kanegane H, Hoshino A, Okano T, Yasumi T, Wada T, Takada H, Okada S, Yamashita M, Yeh TW, Nishikomori R, Takagi M, Imai K, Ochs HD, Morio T.
Flow cytometry-based diagnosis of primary immunodeficiency diseases.
Allergol Int. 2018; 67: 43-54. doi: 10.1016/j.alit.2017.06.003.

Shimizu M, Inoue N, Kuroda M, Irabu H, Takakura M, Kaneda H, Sugimoto N, Ohta K, Yachie A.
Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
Clin Exp Nephrol. 2017; 21: 1083-1087. doi: 10.1007/s10157-017-1391-z.